Recent News

• 09.15.2025 - Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
• 09.10.2025 - Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors
• 08.27.2025 - 100 Days In: Reflections on My First Months at Avanos
• 08.05.2025 - Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors
• 08.05.2025 - Avanos Medical, Inc. Announces Second Quarter 2025 Results
• 07.31.2025 - Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical
• 07.24.2025 - Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
• 06.19.2025 - Why I Joined Avanos: My Vision for Our People and Culture
• 06.11.2025 - The Beauty of Partnerships: Reflections on the Launch of The Pearl
• 06.09.2025 - Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer

Recent Filings

• 09.15.2025 - 8-K Current report
• 09.15.2025 - EX-99.1 EX-99.1
• 09.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.22.2025 - 3 Initial statement of beneficial ownership of securities
• 08.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.05.2025 - EX-99.1 EX-99.1
• 08.05.2025 - 8-K Current report
• 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 06.18.2025 - S-8 Securities to be offered to employees in employee benefit plans